Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study.
Cahill LE, Warren RA, Carew AS, Levy AP, Sapp J, Samuel M, Selvin E, Lavallée SK, Poulter N, Marre M, Harrap S, Mancia G, Harris K, Chalmers J, Woodward M, Rimm EB.
Cahill LE, et al. Among authors: lavallee sk.
Diabetes Care. 2024 May 1;47(5):835-843. doi: 10.2337/dc23-2165.
Diabetes Care. 2024.
PMID: 38484336